Niki BioSolutions, Inc. (NIKI) Other Accumulated Expenses (2017 - 2023)

Niki BioSolutions (NIKI) has 7 years of Other Accumulated Expenses data on file, last reported at $79180.0 in Q4 2023.

• Quarterly Other Accumulated Expenses rose 523.81% year-over-year to $79180.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $79180.0 (up 523.81% YoY) and the FY2025 annual result came in at $79180.0, down 0.58% from the prior year.
• Other Accumulated Expenses retreated to $79180.0 in Q4 2023, from $84405.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $145926.0 in Q4 2020 to a low of $46.0 in Q2 2022.
• A 5-year average of $62451.8 and a median of $60386.5 in 2019 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses plunged 99.97% — and 2023, when it soared 183389.13%.
• Tracing NIKI's Other Accumulated Expenses over 5 years: stood at $41593.0 in 2019, then soared by 250.84% to $145926.0 in 2020, then tumbled by 92.2% to $11389.0 in 2021, then rose by 11.45% to $12693.0 in 2022, then surged by 523.81% to $79180.0 in 2023.
• The last three Other Accumulated Expenses figures came in at $79180.0 (Q4 2023), $84405.0 (Q2 2023), and $12693.0 (Q4 2022), per Business Quant data.